Warner Chilcott Limited (WCRX) - NASDAQ
WCRX is defunct.
  • May 10, 2013, 12:17 PM
    Shares of Actavis (ACT +3%) spike higher on reports the company is in early-stage talks to acquire Warner Chilcott (WCRX +9.5%).
    | May 10, 2013, 12:17 PM
  • May 10, 2013, 7:59 AM
    Warner Chilcott (WCRX): Q1 EPS of $0.45. Revenue of $593M beats by $4.94M. (PR)
    | May 10, 2013, 7:59 AM
  • May 10, 2013, 12:05 AM

    Notable earnings before Friday’s open: AWR, DRH, EVEP, HL, MT, PGNX, TRLG, VTG, WCRX

    | May 10, 2013, 12:05 AM
  • May 9, 2013, 5:30 PM

    Notable earnings before Friday’s open: AWR, DRH, EVEP, HL, MT, PGNX, TRLG, VTG, WCRX

    | May 9, 2013, 5:30 PM
  • May 8, 2013, 9:04 AM
    Warner Chilcott (WCRX) declares $0.25/share semi-annual dividend, in line with previous. Forward yield 3.34%. For shareholders of record May 31. Payable June 14. Ex-div date May 29. (PR)
    | May 8, 2013, 9:04 AM
  • Apr. 12, 2013, 8:44 AM

    Warner Chilcott (WCRX) receives FDA approval for delayed-release 200 mg DORYX tablets (tetracycline) and will launch the product in July. 

    | Apr. 12, 2013, 8:44 AM
  • Feb. 22, 2013, 7:41 AM

    More on Warner Chilcott (WCRX) Q4 earnings: EPS of $0.49 may not be comparable to the $0.73 expected. Company reports Adjusted Cash Net Income of $0.91 after taking out amortization of intangible assets and amortization of deferred loan costs, along with restructuring and litigation charges. Shares remain halted. (PR)

    | Feb. 22, 2013, 7:41 AM
  • Feb. 22, 2013, 7:36 AM
    Warner Chilcott (WCRX): Q4 EPS of $0.91 beats by $0.19. Revenue of $612M (-5% Y/Y) beats by $46.8M. (PR)
    | Feb. 22, 2013, 7:36 AM
  • Feb. 22, 2013, 12:05 AM
    Notable earnings before Friday’s open: AGU, ANF, B, EGO, HMSY, IPG, NVE, WCRX
    | Feb. 22, 2013, 12:05 AM
  • Feb. 21, 2013, 5:30 PM
    Notable earnings before Friday’s open: AGU, ANF, B, EGO, HMSY, IPG, NVE, WCRX
    | Feb. 21, 2013, 5:30 PM
  • Jan. 31, 2013, 4:58 AM

    Endo Health (ENDP) closed +10.8% yesterday following a report that it has held buyout discussions with potential suitors such as Warner Chilcott (WCRX) and Valeant (VRX). Endo, which is looking for a CEO and has a market cap of $3.6B, is not holding an official auction process at the moment.

    | Jan. 31, 2013, 4:58 AM
  • Jan. 28, 2013, 5:43 PM
    After-hours top gainers, as of 5:15 p.m.: FAF +6%. PCL +3%. WCRX +3%. MCRS +3%. GGP +2%.
    After-hours top losers: BMC -7%. EMC -5%. STX -5%. CTXS -4%. FIO -4%.
    | Jan. 28, 2013, 5:43 PM
  • Jan. 4, 2013, 5:50 PM
    After-hours top gainers, as of 5:15 p.m.: OPTR +16%. GTI +9%. DSLV +3%. EGLE +2%. GNMK +2%.
    After-hours top losers: MSPD -8%. CFFN -5%. G -4%. PL -4%. WCRX -2%.
    | Jan. 4, 2013, 5:50 PM
  • Dec. 19, 2012, 1:39 PM

    The index-makers at the Nasdaq are good at selling the bottom: The average one-year return of stocks getting kicked out of the Nasdaq 100 (QQQ) is more than 63%, according to Schaeffer's. "You buy low expectations, not low price," says Ryan Detrick. "Getting kicked out of the QQQ probably is a sign things can't get much worse." Full list of the 10 exiting on Monday.

    | Dec. 19, 2012, 1:39 PM | 1 Comment
  • Nov. 9, 2012, 9:10 AM
    Premarket gainers: ZIP +27%. KYAK +26%. LGF +9%. ENR +8%. PSTI +8%. IGT +7%. WCRX +6%. ISIS +5%.
    Losers: GRPN -23%. MTG -15%. ARRY -12%. PGRX -12%. SPRD -10%. JCP -8%. PVR -6%. CPIX -5%. DIS -5%.
    | Nov. 9, 2012, 9:10 AM | 1 Comment
  • Nov. 9, 2012, 7:35 AM
    Warner Chilcott (WCRX): Q3 EPS of $0.45 misses by $0.33. Revenue of $606M (-7% Y/Y) beats by $47M. (PR)
    | Nov. 9, 2012, 7:35 AM
Company Description
We are a leading global specialty pharmaceutical company currently focused on the gastroenterology, women’s healthcare, dermatology and urology segments of the North American and Western European pharmaceuticals markets. We are a fully integrated company with internal resources dedicated to the... More
Sector: Healthcare
Industry: Drug Manufacturers - Other
Country: United States